Concepedia

Yun Shen

YS

34

Publications

4.6K

Citations

26

H-Index

2008

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Memorial Sloan Kettering Cancer Center

Fox Chase Cancer Center

Princess Margaret Cancer Centre

Sidney Kimmel Comprehensive Cancer Center

Yun Shen is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2008–2023

34

Publications

34

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · JAMA Oncology · 2020 · 1.2K citations · Full text

Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Scott Gettinger, Naiyer A. Rizvi, Laura Q.M. Chow et al. · Journal of Clinical Oncology · 2016 · 493 citations · Full text

Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Julie R. Brahmer et al. · Journal of Clinical Oncology · 2016 · 442 citations · Full text

Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma

Bruno Sangro, Ignacio Melero, Samir Wadhawan et al. · Journal of Hepatology · 2020 · 402 citations · Full text

Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).

Asim Amin, Elizabeth R. Plimack, Jeffrey R. Infante et al. · Journal of Clinical Oncology · 2014 · 231 citations

, , +23

Rows per page

1–5 of 34